Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6237579PMC
http://dx.doi.org/10.1111/jcmm.13871DOI Listing

Publication Analysis

Top Keywords

protective breviscapine
4
breviscapine acute
4
acute pulmonary
4
pulmonary embolism
4
embolism rats
4
rats regulation
4
regulation mcp-1
4
mcp-1 il-13
4
protective
1
acute
1

Similar Publications

Breviscapine (Bre), an extract from Erigeron breviscapus, has been widely used to treat cerebral ischemia but the mechanisms of its neuroprotective effects need to be clarified. The present study investigated whether Bre could alleviate excessive autophagy induced by cerebral ischemia in the rat middle cerebral artery occlusion (MCAO) ischemia model via activating the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 5 (STAT5)/B-cell lymphoma 2 (BCL2) pathway. Rats were randomly divided into 5 groups, i.

View Article and Find Full Text PDF

Purpose: To investigate the protective effect of breviscapine on myocardial ischemia-reperfusion injury (MIRI) in diabetes rats.

Methods: Forty rats were divided into control, diabetes, MIRI of diabetes, and treatment groups. The MIRI of diabetes model was established in the latter two groups.

View Article and Find Full Text PDF

Breviscapine protects against pathological cardiac hypertrophy by targeting FOXO3a-mitofusin-1 mediated mitochondrial fusion.

Free Radic Biol Med

February 2024

State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China. Electronic address:

Forkhead box O3a (FOXO3a)-mediated mitochondrial dysfunction plays a pivotal effect on cardiac hypertrophy and heart failure (HF). However, the role and underlying mechanisms of FOXO3a, regulated by breviscapine (BRE), on mitochondrial function in HF therapy remain unclear. This study reveals that BRE-induced nuclear translocation of FOXO3a facilitates mitofusin-1 (MFN-1)-dependent mitochondrial fusion in cardiac hypertrophy and HF.

View Article and Find Full Text PDF

The present study investigated the therapeutic potential of breviscapine (Bre) in mitigating lead (Pb)-induced myocardial injury through activation of the nuclear factor erythroid-2 related factor 2 (Nrf2) pathway. Rat cardiomyocytes (H9C2 cells) were exposed to Pb to model Pb poisoning, and various parameters, including cell viability, apoptosis and reactive oxygen species (ROS) production, were assessed using Cell Counting Kit-8, flow cytometry and 2',7'-dichlorfluoresceindiacetate assays, respectively. Additionally, a rat model of Pb poisoning was established in which blood Pb levels were measured using a graphite furnace atomic absorption spectrophotometer, and alterations in myocardial tissue, oxidative stress markers, inflammatory indicators, protein expression related to apoptosis and the Nrf2 pathway were evaluated via histopathology, ELISA and western blotting.

View Article and Find Full Text PDF
Article Synopsis
  • Erigeron breviscapus is a traditional medicine used by several ethnic minorities in China for treating ailments, including ischemic stroke, although its mechanisms are not fully understood.
  • This study employs advanced metabonomics techniques to understand how Erigeron breviscapus injection impacts a rat model of ischemic stroke and its interactions with mitochondrial apoptosis pathways.
  • Results indicate that the injection significantly reduces cerebral infarction size and improves tissue health, as evidenced by an increase in Nissl bodies in the treated rats.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!